Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study
| Autor: | Chen, Yilin, Martin, Peter, Inoue, Lurdes Y.T., Basu, Anirban, Carlson, Josh J. |
|---|---|
| Zdroj: | In Value in Health July 2024 27(7):926-935 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect